
Advanced Technology to Address Today’s Challenges of
Health Care Associated Infections (HAI’s)
Transparency
State and Federal legislation for mandatory reporting are driving hospitals to reduce HAIs to increase patient safety and quality of care.
Profitibility
Medicare begins reduced payment for HAIs starting October of 20081.
HAIs reduce inpatient margins by an average of $5,0182.
MRSA HAIs are estimated to cost an average of $35,000 and increase Length of Stay by up to 10 days3.
Strain typing helps reduce HAI’s
Studies indicate that incorporating a strain-typing program in your institution reduces your HAI rate by up to 23%4.
Need for rapid strain typing
Rapid results are required to help Infection Control Practitioners locate the source of microbial outbreaks quickly.
The DiversiLab® System provides same day strain typing for real-time epidemiological investigations. The highly reproducible fingerprint patterns can be stored to facilitate historical tracking and help uncover hidden reservoirs of resistance.
As part of a comprehensive Infection Control program, the DiversiLab System will help track the source and spread of microbial infections and contamination more quickly, more accurately, and more cost-effectively than any other solution on the market.
Where Can I Use Diversilab?
Outbreak Investigation
- Compare samples from multiple patients, locations or dates
- Control the spread of nosocomial infections using real-time tracking
- Apply to forensics for biothreat agents
Environmental Monitoring
- Compare air quality samples
- Identify contaminated equipment
Trend Analysis
- Database samples for long-term studies
- Track seasonal outbreaks from year to year
References
1 Centers for Medicare and Medicaid Services, found at http://www.cms.hhs.gov/HospitalAcqCond.
2 Murphy D, Whiting J, Dispelling the Myths: The True Cost of Healthcare-Associated Infections,
Feb 2007, www.apic.org.
3 Association for Professionals In Infection Control and Epidemiology, Methicillin Resistant Staphylococcus Aureus Backgrounder, found at: http://www.apic.org/Content/NavigationMenu/ResearchFoundation/NationalMRSAPrevalenceStudy
/MRSABackgrounder.pdf.
4 Peterson F, Noskin G, New Technology for Detecting Multidrug-Resistand Pathogens in the Clinical Microbiology Laboratory, Emerging Infectious Diseases, Vol. 7, No. 2, March-April 2001: 306-311. |